The supply of genuinely new drugs has just about dried up. No wonder pharmaceutical companies are so keen to protect their patents on existing drugs - The Business - Column

The pharmaceutical business was once run by men and women in white coats. Heroic figures, they peered into test tubes and Petri dishes.

» more

With RFID, drugs go their own way: the pharmaceutical industry is unique in its demands on radio frequency identification

When it comes to RFID, the pharmaceutical industry is as different from other markets as a pill is from an M&M.

» more

Securing the drugs supply: international regulation may soon compel pharmaceutical firms to employ supply chain technologies to secure and verify their products at every stage of distribution. But those that get it right should also reap operational and financial benefits, setting a benchmark for other industries with complex supply issues

Just as the Sarbannes-Oxley legislation in the USA is having a knock on effect for companies around the world, the global pharmaceutical industry will be affected by current guidelines.

» more

Doping kids: as pharmaceutical companies push their products, more and more kids are being treated with powerful—and untested—adult drugs - Outfront

For Dr. Stephen Borowitz, the most frustrating office visits are with parents of kids suffering from stomachaches and infants prone to spitting up.

» more


Generics still a profit stream

Generics still a profit stream as pharmacy margins trickle - generic drugsCosts of generic drugs are going up on the supply side, say chain drug pharmacy executives, as competition dries up and multisource products shrink to a single supplier or handful of suppliers.

Cardinal health ramps

Cardinal health ramps up drug manufacturing capabilities - Cardinal Health acquires pharmaceutical plant from Schering-Plough - Brief Article - Statistical Data IncludedBASKING RIDGE, N.J. -- Cardinal Health's recent purchase of an idle Schering-Plough plant in Raleigh, N.C., underscores the $40 billion wholesaler's growing presence in the drug-making process.

The Suffocation of Innovation

The Suffocation of Innovation: When the Left fights progress, fight back - prescription drug coverage and new drugsA few years ago, I took part in a congressional hearing on prescription-drug coverage for seniors. During the hearing, Robert Reischauer -- the former director of the Congressional Budget Office and now a budget expert at the Urban Institute

New systems for counterfeit

New systems for counterfeit protection and quality control: counterfeiting prevention has joined quality control as a top concern for pharmaceutical manufacturers. Both issues received a high level of attention at the recent Interphex and Interpack trade exhibitionsProduct security and quality control were major themes of this year's Interphex trade show, held April 26-28 in New York City. A variety of interesting packaging machinery innovations were featured at the event.